| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Circulation, Vol 90, 1185-1193, Copyright © 1994 by American Heart Association
CC Cowie, BV Howard and MI Harris
BACKGROUND: Despite the significant role that dyslipidemia is believed to
play in the development of cardiovascular disease in diabetes, most studies
examining diabetic dyslipidemia in the United States have not been
population based, and very little data are available for African Americans
with diabetes. We used data from a national survey to compare the effect of
diabetes on lipid concentrations in African-American and white men and
women. In addition, we examined other factors related to lipid
concentrations and controlled for these factors in our analyses. METHODS
AND RESULTS: The Second National Health and Nutrition Examination Survey
included a representative sample of 4177 African Americans and whites in
the US civilian noninstitutionalized population 20 to 74 years old. These
persons were classified as having non-insulin- dependent diabetes mellitus
(NIDDM) (n = 720) or as being nondiabetic (n = 3457) based on an oral
glucose tolerance test and a medical history of diabetes. Subjects were
given an interview and physical examination that included measurement of
serum lipoproteins, body mass index, body fat distribution, dietary fat
intake, alcohol consumption, frequency of smoking, and use of medications.
By univariate analysis, a worse profile of mean cholesterol, triglycerides,
and high-density lipoprotein cholesterol levels was generally apparent in
NIDDM than in nondiabetic subjects, regardless of race or sex; a similar
pattern was found for the prevalence of abnormal concentrations of these
lipids. Lipid profiles appeared to be worse in whites with NIDDM than in
African Americans. For mean total and low-density lipoprotein cholesterol,
concentrations tended to be worse in women with NIDDM than in men. When
other factors significantly affecting lipid levels were adjusted by
multivariate analysis, we found that in all race/sex groups, total
cholesterol was higher in NIDDM than in nondiabetic subjects but
differences were not significant (P = 54), triglyceride concentrations were
significantly higher in NIDDM subjects (P < .0001), and high-density
lipoprotein cholesterol concentrations were lower in NIDDM subjects (P =
.003). An interaction of diabetes with race was found for low-density
lipoprotein cholesterol (P = .0001), where concentrations were
substantially lower in NIDDM than in nondiabetic subjects among African
Americans (P < .01) but slightly higher in NIDDM subjects among whites
(P = .33). For other lipids, no differential effect of NIDDM was found by
race or sex. CONCLUSIONS: In African- American and white men and women in
the United States, NIDDM is associated with a pattern of dyslipidemia that
may potentiate the atherosclerotic process. Diabetic treatment should
include aggressive treatment of dyslipidemia to reduce this increased risk.
ARTICLES
Serum lipoproteins in African Americans and whites with non-insulin- dependent diabetes in the US population
Social and Scientific Systems, Inc., Bethesda, Md 20814.
This article has been cited by other articles:
![]() |
A. Muscari, S. Antonelli, G. Bianchi, G. Cavrini, S. Dapporto, A. Ligabue, C. Ludovico, D. Magalotti, G. Poggiopollini, M. Zoli, et al. Serum C3 Is a Stronger Inflammatory Marker of Insulin Resistance Than C-Reactive Protein, Leukocyte Count, and Erythrocyte Sedimentation Rate: Comparison study in an elderly population Diabetes Care, September 1, 2007; 30(9): 2362 - 2368. [Abstract] [Full Text] [PDF] |
||||
![]() |
the Diabetes Prevention Program Research Group Lipid, Lipoproteins, C-Reactive Protein, and Hemostatic Factors at Baseline in the Diabetes Prevention Program Diabetes Care, October 1, 2005; 28(10): 2472 - 2479. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Poynten, S. K. Gan, A. D. Kriketos, L. V. Campbell, and D. J. Chisholm Circulating Fatty Acids, Non-High Density Lipoprotein Cholesterol, and Insulin-Infused Fat Oxidation Acutely Influence Whole Body Insulin Sensitivity in Nondiabetic Men J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 1035 - 1040. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. G. Solomon, F. B. Hu, M. J. Stampfer, G. A. Colditz, F. E. Speizer, E. B. Rimm, W. C. Willett, and J. E. Manson Moderate Alcohol Consumption and Risk of Coronary Heart Disease Among Women With Type 2 Diabetes Mellitus Circulation, August 1, 2000; 102(5): 494 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. V. Howard, D. C. Robbins, M. L. Sievers, E. T. Lee, D. Rhoades, R. B. Devereux, L. D. Cowan, R. S. Gray, T. K. Welty, O. T. Go, et al. LDL Cholesterol as a Strong Predictor of Coronary Heart Disease in Diabetic Individuals With Insulin Resistance and Low LDL : The Strong Heart Study Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 830 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Chaturvedi, J. Jarrett, N. Morrish, H. Keen, and J. H Fuller Differences in mortality and morbidity in African Caribbean and European people with non-insulin dependent diabetes mellitus: results of 20 year follow up of a London cohort of a multinational study BMJ, October 5, 1996; 313(7061): 848 - 852. [Abstract] [Full Text] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1994 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |